The kinomes of apicomplexan parasites by Miranda-Saavedra, D. et al.
  
 
 
 
 
 
Miranda-Saavedra, D., Gabaldón, T., Barton, G., Langsley, G., and Doerig, 
C. (2012) The kinomes of apicomplexan parasites. Microbes and Infection, 
14 (10). pp. 796-810. ISSN 1286-4579 
 
 
 
Copyright © 2012 Institut Pasteur 
 
A copy can be downloaded for personal non-commercial research or 
study, without prior permission or charge  
 
The content must not be changed in any way or reproduced in any format 
or medium without the formal permission of the copyright holder(s)   
When referring to this work, full bibliographic details must be given 
 
 
 
 
 
 
http://eprints.gla.ac.uk/73296/ 
 
 
 
 
 
 
Deposited on:  6th February 013 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Enlighten – Research publications by members of the University of Glasgow 
http://eprints.gla.ac.uk 
	 1
The kinomes of apicomplexan parasites 
 
  Diego Miranda-Saavedra1*, Toni Gabaldón3, Geoffrey J. Barton2,  
   Gordon Langsley4,5 and  Christian Doerig6 
 
1Bioinformatics and Genomics Laboratory, WPI Immunology Frontier Research Center 
(IFReC), Osaka University, 3-1 Yamadaoka, Suita, 565-0871, Osaka, Japan. 
 
2Division of Biological Chemistry and Drug Discovery, College of Life Sciences, University 
of Dundee, Dow Street, Dundee DD1 5EH, UK. 
 
3Bioinformatics and Genomics Programme, Centre de Regulació Genòmica/Universitat 
Pompeu Fabra, Doctor Aiguader, 88. 08003 Barcelona, Spain. 
 
4Université Paris Descartes, Sorbonne Paris Cité, Institut Cochin, CNRS UMR 8104, 75014 
Paris, France. 
 
5Inserm U1016, 75014 Paris, France. 
 
6Monash University, Melbourne, Australia 
 
 *Author for correspondence: E-mail. diego@ifrec.osaka-u.ac.jp; Tel. +81 0 6 6879 4269;   
 Fax. +81 6 6879 4272  
 
 
 
 
 
 
 
Abstract 
 
Protein phosphorylation plays a fundamental role in the biology and invasion strategies of 
apicomplexan parasites. Many apicomplexan protein kinases are substantially different from their 
mammalian orthologues, and thus constitute a landscape of potential drug targets. Here, we integrate 
genomic, biochemical, genetic and evolutionary information to provide an integrated and up-to-date 
analysis of twelve apicomplexan kinomes. All kinome sequences are available through the Kinomer 
database. 
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1. Introduction 
 
The reversible modification of protein by phosphorylation, as carried out by protein kinases (PKs) and 
phosphatases is a major mechanism that regulates virtually every aspect of cellular life [1]. Not 
surprisingly, when protein phosphorylation goes awry serious diseases such as neurodegenerative 
disorders and cancers occur as a result [2]. The protein kinase superfamily is broadly classified into 
eight ‘conventional’ PK (ePK) groups (AGC, CAMK, CK1, CMGC, RGC, STE, TK, TKL) and four 
‘atypical’ PK (aPK) groups (Alpha, PDHK, PIKK, RIO). The ePKs possess the characteristic PK 
catalytic domain, as described by Hanks and Hunter [3]. Some ePKs, whilst exhibiting some degree of 
sequence similarity to the main ePK groups, cannot be easily classified into any such group, thus 
constituting a loose cluster on its own called the ‘Other protein kinases’ (OPK) group. The aPKs are a 
small set of PKs that do not share sequence similarity with ePKs, but nevertheless possess kinase 
catalytic activity. Given the central importance of protein phosphorylation to the cell, the 
characterization of the PK complement (‘kinome’) of an organism is bound to offer important 
biochemical insights and, in the case of pathogenic organisms, project a landscape of potential drug 
targets [4, 5]. Many PKs of parasitic organisms show a profound structural and functional divergence 
from their orthologues in the infected hosts (when they exist), suggesting that parasite-specific 
inhibition might be achieved. A striking example is given by the elegantly documented selective 
inhibition allowed by small gatekeeper residues displayed by some kinases from apicomplexan parasites 
[6-9].  
 The kinome of the human malaria parasite Plasmodium falciparum [10, 11] comprises 
approximately 90 PKs, many of which are not related to established families of higher eukaryotes, and 
lacks both tyrosine kinases and canonical MAP kinase cascades. The genus Plasmodium belongs to the 
phylum Apicomplexa, a large and diverse group of unicellular protists within the Alveolata taxonomic 
group. All Apicomplexa are obligate intracellular parasites. The biodiversity and wide environmental 
distribution of apicomplexans is astounding, with an estimated 1.2-10 million species, of which only 
~0.1% have been named to date [12]. They are responsible for many debilitating diseases both in 
developing countries and in industrialised nations. P. falciparum causes 300-600 million clinical cases 
per year [13], resulting in 1.5-3 million deaths [14, 15]. Mortality caused by malaria has decreased in 
recent years, notably thanks to the introduction of artemisinin combination therapies (ACT). However, 
this may be a short-lived respite, as reduced sensitivity to arteminin-derived compounds has already 
been documented [16]. P. vivax also infects humans, but is less virulent than P. falciparum [17], and P. 
knowlesi was primarily known to cause malaria in macaques [18], but has recently been identified as 
capable of infecting humans [19]. The rodent malaria parasites P. berghei, P. chabaudi and P. yoelii 
are model organisms for the study of pathogenesis and parasite biology [20, 21]. Both Theileria species 
are tick-borne haemoparasites of cattle, T. parva causing East Coast fever [22, 23], and T. annulata 
causing tropical theileriosis [24]. Besides their economic importance, Theileria species are of great 
biological interest in the context of mammalian cell transformation, because they are the only 
intracellular eukaryotic pathogens known to reversibly transform their host cells through the hijacking 
of a number of its signalling pathways [25-27]. Toxoplasma gondii causes toxoplasmosis, a serious 
disease in immunocompromised patients that is prevalent worldwide, with an estimated 1/3 of the 
World’s population infected with the parasite [28]. Recently, a link has been found between T. gondii 
infection and schizophrenia and paranoia [29]. The two Cryptosporidium species cause acute 
gastroenteritis and diarrhoea worldwide and differ in their host range: although both species exhibit 
very similar gene complements, C. hominis infects only humans [30], whereas C. parvum also infects 
other mammals [31]. Finally, Babesia bovis causes haemolytic anemia in cattle, one of the most 
important arthropod-transmitted diseases of cattle and for which no vaccine is available. Although 
babebiosis has been eradicated in the United States, it is still present in many tropical regions, posing a 
serious constraint to economic development [32]. 
 Here, we exploit recent efforts in parasite genomics to compare the kinomes of twelve 
apicomplexan species. These include five species, whose kinomes have been described in detail: P. 
falciparum [10, 11], P. yoelii [33], P. berghei  [34], T. gondii [35, 36] and C. parvum [37]. 
Furthermore, we report the initial characterization of seven apicomplexan kinomes, including P. 
chabaudi, P. knowlesi, and P. vivax, C. hominis, T. annulata and T. parva, as well as B. bovis. The 
published kinomes are reassessed and combined with the new ones by using our own validated 
computational tool for kinome characterisation (Kinomer). All kinomes are described with reference 
both to metazoan and alveolate kinomes. We outline important orthologous groups of kinases shared 
with other alveolates and metazoans, and a large number of Apicomplexa-specific orthologous kinases, 
which are likely to be important for the parasites’ life cycle and invasion strategies, and thus constitute 
potentially attractive drug targets. 
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2. A comprehensive census of apicomplexan kinomes 
 
A number of kinomes have been published to date, but their comparison is not straightforward for the 
following reasons: (i) they have been analysed using a variety of sequence analysis tools and pipelines 
with various degrees of sensitivity and classification accuracy; (ii) some kinomes only include the ePK 
complement (and not the aPKs); (iii) the extent of assignment of orthology relationships to higher 
eukaryotic kinomes vary widely. To overcome these inconsistencies, we have analysed the kinomes of 
twelve apicomplexan species using a validated computational tool, called Kinomer, that is specific for 
eukaryotic protein kinases (see Supplementary Materials and Methods). We have previously reported 
Kinomer to have a mis-classification rate of zero on the kinase group classification level, with the 
additional advantage that it is more sensitive for protein kinase database searches than general 
sequence analysis tools. Here, we used Kinomer to mine the latest apicomplexan genome database 
releases (as of February 2012) to provide a comprehensive and unified view of existing and novel 
apicomplexan kinomes. 
 
2.1. Comparison with the published kinomes of P. falciparum, P. yoelii, P. berghei, C. parvum and 
T. gondii 
 
Several independent groups have previously published their accounts of the kinomes of P. falciparum 
[10, 11], P. yoelii [33], P. berghei [34] and T. gondii [35]. We have performed our own analyses with 
the multi-level kinase HMM library and the most up-to-date genome versions, and our comparisons 
with the published studies above stand as follows. 
 The survey of the P. falciparum kinome by Anamika et al. [11] identified 99 PKs, including 
80 ePKs and 19 FIKK enzymes. Their classification of ePKs into kinase groups essentially agrees with 
that of Ward et al. [10] and the refined classification presented here, except for their inclusion of 
PF14_0516 into the AGC group. Our study suggests that this enzyme is a CAMK related to the 
catalytic subunit of AMPK. Anamika et al. included 7 putative ePKs that were not retained in the study 
by Ward and co-workers. These sequences are very degenerate, lack several of the canonical amino 
acid residues of the 12 sub-domains of the kinase catalytic domain [3] and therefore, are not included 
in our analysis either. Ward et al. proposed a P. falciparum kinome comprising 65 ePKs, 3 aPKs and 
20 novel FIKK enzymes. Of these, we found that PFI1290w had been fused with PFI1285w in 
subsequent database releases, and that the FIKK kinase PFI0125c had been removed too. Here, we 
have identified 3 new P. falciparum kinases: PF11_0079 (TKL group), plus PFD0965w and 
PFE0485w (both atypical kinases of the PIKK family). This brings the updated kinome of P. 
falciparum to 89 PKs, with 65 ePKs, 19 FIKKs and 5 aPKs. 
 With regard to the P. yoelii kinome, we have identified 63 PKs versus 60 from the Anamika 
and Srinivasan study [33]. From their study we have excluded 4 PKs: three possess truncated kinase 
catalytic domains (PY00266, PY04849, PY02490) and one is not a recognizable PK (PY00132). We 
have identified 9 additional PKs that had not been reported previously (PY05890 (CMGC), PY02456 
(NEK), PY02993 (OPK), PY04175 (OPK), PY07525 (OPK), PY00334 (PIKK), PY01572 (RIO) and 
PY06287 (RIO)). Thus, we propose that the P. yoelii kinome contains 63 PKs, with 60 ePKs and 3 
aPKs. 
 Tewari et al. recently published a description of the P. berghei kinome together with a 
kinome-wide reverse genetics analysis, revealing the role for a number of PKs in infection of the 
mosquito vector [34]. Our own analysis of the P. berghei kinome essentially agrees with that of Tewari 
et al. 
 Peixoto et al. recently analysed the T. gondii kinome [35]. The authors report 159 PKs, 
including 39 members of a novel family call ROPK (from their association with the rhoptries, 
apicomplexan-specific organelles involved in the process of host cell invasion). Our classification in 
general agrees with this analysis on the group-level classification of kinases, but not always on the 
homology relationships of individual PKs. This is partly because a comparative analysis including 
many different genomes is richer in the number of homologous sequences and is thus bound to improve 
the clarity of phylogenetic relationships. Our account of 135 PKs in the T. gondii kinome excludes a 
number of PKs reported by Peixoto et al. as they harbour truncated kinase catalytic domains. 
 Finally, inspection of the C. parvum kinome suggested that our classification broadly agrees 
with the published set of identified PKs [37], although not always on the PK group level classification, 
or the inclusion of fragmentary PK catalytic domains. The recent analysis by Talevich et al. [38] sought 
to investigate multiple apicomplexan kinomes with the purpose of analysing specific PK families both 
from an evolutionary and a structural point of view. Our inspection of their dataset suggests that 
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although a majority of true PKs were identified, their study did not include some of the most distant 
sequences. 
 
2.2. Overview of apicomplexan kinomes 
 
Apicomplexan kinomes are smaller than that of S. cerevisiae, with kinome sizes ranging from a 
surprisingly small set of 35 sequences (B. bovis) to 135 (T. gondii), with 0.8-1.7% of apicomplexan 
genes encoding PKs (Table 1). Apicomplexans harbour kinases of all the main ePK groups except 
receptor guanylate cyclase (RGC) and tyrosine kinases, and also lack members of the PDHK (except 
for T. gondii) and Alpha aPK families. The contribution of each PK group to the entire kinome is 
conserved between apicomplexans and higher eukaryotes (Fig. 1). Over the next sections, we describe 
twelve apicomplexan kinomes on a kinase group basis, and discuss the 65 orthologous groups of PKs 
that are shared with other alveolates and/or metazoans. Of these orthologous groups, 11 (17%) are 
shared with both alveolates and metazoans, 6 orthologous groups (9%) are shared with other alveolates 
only, and 48 groups (74%) are Apicomplexa-specific. We take the P. falciparum orthologues as the 
starting point of discussion, taking advantage of the thorough characterization of many of this 
parasite’s PKs in recent years. 
 
2.3. The AGC group 
 
The AGC group (including cyclic-nucleotide and calcium/phospholipid-dependent kinases, ribosomal 
S6-phosphorylating kinases, G protein-coupled kinases and all close relatives of these sets) contains 
kinases found in all eukaryotes examined to date. The AGC group of apicomplexans comprises 6 
orthologous groups, three of which are shared with alveolates and metazoans (exemplified by PfPKA, 
PfPKB/Akt and PfPKG), and three that are restricted to Apicomplexa (Fig. 2, Table S1). All six AGC 
kinases of P. falciparum are essential during the erythrocyte stage. 
 PfPKA is a universally conserved cAMP-dependent kinase (Haste et al in press, and see pages 
XX in this issue), whose expression in P. falciparum is developmentally regulated, with higher levels 
in the pathogenic asexual stages than in the sexual forms. Pharmacological data with the H89 PKA 
inhibitor, and the inability to produce P. berghei clones lacking a functional PbPKA gene [34], strongly 
suggest that PKA is essential for Plasmodium schizogony [39] (although it cannot be excluded that the 
inhibitor has other targets in addition to PKA). cAMP-dependent activity is implicated in the 
phosphorylation of the cytoplasmic tail of apical membrane antigen 1 (AMA1), a membrane protein 
essential for erythrocyte invasion [40], and in the regulation of an anion channel in P. falciparum-
infected erythrocytes [41]. 
 PfPKB/Akt is expressed mainly in schizonts and merozoites and is likely to be important for 
parasite development, as PKB inhibitors arrest P. falciparum growth, and the P. berghei orthologue 
appears to be essential to asexual blood stage parasites [34, 42]. Interestingly, PfPKB/Akt has 
homologues in all Plasmodium species and in T. gondii, but has been lost from piroplasmids and 
gregarines. The likely essential function of PfPKB/Akt in haemosporidians and coccidians must have 
been taken over by another PK in these taxons. PfPKB/Akt is activated by autophosphorylation, and 
unlike the PKBs of higher eukaryotes, all PKBs of the Apicomplexa lack lipid-binding pleckstrin-
homology (PH) domains; interestingly, one of the calcium-dependent kinases, CDPK7, contains a PH 
domain (see below). The N-terminal region of PfPKB/Akt harbours an unconventional calmodulin-
binding domain, whose activation upon calmodulin binding ultimately regulates PfPKB/Akt activity in 
a calcium-dependent manner [43]. The PfPKB homologues of the non-apicomplexan alveolates 
Phytophthora ramorum and P. sojae, however, do contain N-terminal Phox-like domains that 
characteristically bind phosphoinositides. This domain is not present in the homologue of the diatom 
Thalassiosira pseudonana, thus illustrating the divergent organization of signal transduction 
mechanisms in apicomplexans.  
 The cGMP-dependent protein kinase PfPKG regulates cGMP signalling in the malaria 
parasite, and has orthologues in all apicomplexans, alveolates and metazoans. PKG has been shown to 
be essential in Eimeria (a pathogen of poultry) and Toxoplasma [6], and the tri-substituted pyrrole 
pyrimidine Compound 1that targets Eimeria PKG has a much lower effect (by 3 orders of magnitude) 
on chicken PKG. This was shown to be due to the presence of a gatekeeper residue that is smaller in 
the apicomplexan (a Thr) than in metazoan (a Gln) PKG. Compound 1 was subsequently shown to 
inhibit P. falciparum proliferation in vitro [44]. The effect of Compound 1 on blood-stage schizogony 
has recently revealed that cGMP signaling and PfPKG play a central role in both asexual and sexual 
development of P. falciparum [7, 45]. The role of PKG in regulating the malaria parasite’s life cycle 
progression has recently been reviewed by Hopp et al. (Hopp et al. in press, and see pages XX in this 
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issue). PfPKG is characterized by the presence of three cyclic nucleotide-binding domains and a fourth 
degenerate site which does not bind cGMP, but is nevertheless required for full activation of the 
enzyme. Combinatorial mutational analysis has revealed different degrees of importance of the cyclic 
nucleotide binding domains in PfPKG activation [46]. PKG homologues have not been characterised in 
Leishmania or Trypanosoma. 
 
2.4. The CAMK group 
 
The CAMK group (including calcium/calmodulin-regulated kinases) is the second largest kinase group 
in apicomplexans, in agreement with the growing experimental evidence of a central role for calcium 
signalling in the biology of these parasites. The CAMKs of apicomplexans consist of 18 orthologous 
groups, only one of which is shared with both metazoans and other alveolates, while another group is 
shared with other alveolates only, and a further 16 are specific to apicomplexans (Fig. 2, Table S1). 
This makes the CAMK the group with the lowest assignment of putative orthology both to enzymes of 
higher eukaryotes and to those of non-apicomplexan alveolates. Moreover, nine of the sixteen CAMKs 
of P. falciparum are essential, suggesting that Apicomplexa-specific CAMKs can be expected to carry 
out important functions in unique aspects of apicomplexan biology. As detailed below, this has been 
documented in several instances. 
 PfKIN, the malarial orthologue of the catalytic subunit of AMP-dependent PK (SNF1 in 
yeast) represents the only orthologous group that is shared with alveolates and metazoans. Yeast SNF1 
plays a role in transcriptional activation and repression to respond to several forms of stress such as 
nutrient limitation, salt stress and heat shock (reviewed in [47, 48]). PfKIN is predominantly expressed 
in gametocytes [49], and accordingly reverse genetics in P. berghei indicates that the gene product is 
not required for the erythrocytic asexual cycle.  
 A family of seven calcium-dependent PKs (PfCDPKs) has previously been described in the 
malaria parasite (reviewed in [50]). CDPKs have been implicated in transmitting calcium-mediated 
responses to biotic and abiotic stresses and developmental signals in plants, ciliates, and 
trypanosomatids [51], and are represented in all apicomplexans surveyed, with the majority of 
orthologues harbouring the characteristic four EF-hand calcium-binding domains. Most importantly, 
CDPKs are absent from mammalian hosts. Structural studies on their mechanism of intramolecular 
activation showed that the N-terminal lobe of the calmodulin-like domain functions as the calcium 
sensor that triggers activation [52, 53]. As shown with the T. gondii CDPK1 orthologue (TgCDPK1), 
activation of the enzyme upon calcium binding occurs through a large conformational change. The 
binding of calcium reorganizes the C-terminal CDPK activation domain (CAP) causing its relocation to 
a site distant from the substrate binding site [54]. Moreover, TgCDPK1 has been shown to be an 
essential regulator of calcium-dependent exocytosis by controlling the calcium-dependent secretion of 
micronemes, and blocking TgCDPK1 inhibits parasite motility, host-cell invasion and egress [9]. 
PfCDPK1 is expressed in the asexual blood stages of P. falciparum, and characterized substrates 
include MTIP and GAP45, two components of the motor complex required for host-cell invasion. 
PfCDPK1 is inhibited by the kinase inhibitor K252a [55]. Since CDPK1 is conserved among 
apicomplexans, but is absent from mammalian hosts, it is an attractive potential target for antimalarial 
drug development. The subcellular localization of some CDPK isoforms is dynamic, as shown by the 
shift of a plasma membrane CDPK to the nucleus following stress signals (reviewed in [56]). 
PfCDPK1 has been shown to be myristylated and to localize at the parasitophorous vacuole [57]. An 
essential function in gamete formation and mosquito transmission has been ascribed to the P. berghei 
homologue of PfCDPK4 (PbCDPK4) [58]. Targeted disruption of PbCDPK3 decreases the calcium-
dependent ookinete gliding mobility and ability to penetrate the layer covering the mosquito midgut 
epithelium, thereby decreasing the fertilization rate of the parasite [59, 60], whereas parasite lacking 
PbCDPK6 are impaired in their ability to invade hepatocytes [61]. The wide phylogenetic distribution 
of CDPKs suggests that regulation by calcium signalling is an ancient mode of regulation. Since 
CDPKs are an ancient family that was secondarily lost in metazoans, they represent potentially 
attractive targets for chemotherapeutic and transmission-blocking intervention. 
 The P. falciparum CDPK7 (PF11_0242), in addition to a calcium-binding EF-hand domain, is 
notable for harbouring a pleckstrin-homology domain and has orthologues in all apicomplexans (except 
cryptosporidians), and also in alveolates. In mammals PH domain-containing kinases are regulated by 
lipids, but as mentioned above none of the apicomplexans PKB/Akt orthologues contain a lipid-binding 
domain. This provides another striking illustration of the divergence in the organization of signalling 
pathways between apicomplexans and opisthokonts, as well as the difficulty in predicting function on 
the basis of kinase catalytic domain phylogeny alone. 
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2.5. The CK1 group 
 
The CK1 group (casein kinase 1 and close relatives) enzymes are implicated in diverse cellular 
functions, including cell cycle progression, chromosome segregation, membrane trafficking, apoptosis 
and cellular differentiation [62-64]. All apicomplexans share an orthologous group of CK1 enzymes, 
which form a compact cluster unrelated to CK1s of other alveolates or metazoans (Fig. 2, Table S1), 
thus stressing the phylogenetic distance between these taxons and suggesting a potential for selective 
inhibition. The P. falciparum kinase PfCK1 is an essential enzyme, and each apicomplexan species was 
found to possess one CK1 enzyme. Two of the T. gondii CK1 enzymes (TGME49_040640 
(TgCK1alpha) and TGME49_089320 (TgCK1beta)) were cloned and the recombinant molecules 
assayed for activity. The plasma-membrane isoforms (TgCK1beta) showed no kinase activity, whereas 
the cytosolic isoform (TgCK1alpha) was found to be catalytically active and inhibited in vitro by 
purvalanol B and also by the cell-permeable and related compound aminopurvalanol A with an IC50 of 
42±7 nm for the recombinant enzyme (versus an IC50=4000 nm for rat CK1delta). This suggested the 
existence of potentially exploitable structural differences between metazoan and parasitic CK1 enzymes 
[65]. Since aminopurvalanol A inhibits parasite growth, CK1 inhibitors are potential leads for anti-
parasitic agents. Interestingly, the cell-impermeable purvalanol B displays activity against P. falciparum 
[66], and affinity chromatography on the immobilised inhibitor identified PfCK1 as a putative target 
[67]. The inhibitors tri-substituted pyrrole and imidazopyrine exhibit in vivo efficacy against PKG in 
Eimeria tenella in chickens and T. gondii in mice, but also inhibit apicomplexan CDPK1 and CK1 [68]. 
When tested in Trypanosoma brucei and Leishmania major (which lack PKG homologues), these PKG 
inhibitors were found to be selective against the trypanosomatid CK1 enzymes [69]. The P. berghei 
CK1 orthologue is likely to be essential, as suggested by the inability to obtain knock-out parasites [34]. 
 A second, smaller, cluster includes cryptosporidian and Toxoplasma CK1s that are related to 
CK1s of Paramecium and Tetrahymena, thus highlighting the evolutionary relationship of 
apicomplexans and alveolates. 
 
2.6. The CMGC group and other cell cycle control kinases 
 
The CMGC group (including cyclin-dependent kinases, mitogen-activated PKs, glycogen synthase 
kinases and CDK-like kinases) is the largest PK group in apicomplexans, as well as in trypanosomatids 
[51]. The CMGC group harbours 22 orthologous groups of kinases, 7 of which are found in alveolates 
and metazoans, 4 are found in apicomplexans and non-apicomplexan alveolates, and 11 are 
Apicomplexa-specific (and of which 7 are found in haemosporidians only) (Fig. 2, Table S1). 
Therefore, ~70% of CMGC orthologous groups are specific to alveolates and not found in metazoans. 
 P. falciparum has two GSK-3-related enzymes (both of which are essential), one of which is 
found in haemosporidians only (MAL13P1.84), while PfGSK3 (PFC0525c) is shared with other 
alveolates and metazoans. In humans, GSK3 is a multifunctional kinase affecting a diverse range of 
cellular functions, including the regulation of metabolism, gene expression, and even cell fate 
determination and the spatial organization of the embryo [70, 71]. The clarification of GSK3’s role in 
insulin regulation in the mid-90’s has led to the development of an arsenal of very potent and specific 
inhibitors with therapeutic potential for the treatment of diabetes [72]. 
 P. falciparum possesses two MAP kinases, and only Pfmap-1 (PF14_0294) has orthologues in 
other alveolates and metazoans, whereas Pfmap-2 (PF11_0147) is an essential enzyme shared with 
other alveolates only. Despite the existence of MAP kinases, apicomplexans do not seem to have 
complete MAP kinase cascades [73], as canonical MAPKKs appear to be missing from their kinomes. 
 PfCK2 (PF11_0096) is another highly conserved kinase in the CMGC group that is shared 
with other alveolates and metazoans, and has been implicated in critical cellular processes such as 
proliferation, apoptosis, differentiation and transformation [74]. The observations that PfCK2 is 
essential for completion of the parasite’s asexual erythrocytic proliferation, and that the plasmodial and 
human CK2 enzymes display differential susceptibility to some inhibitors, makes PfCK2 a potential 
drug target [75]. 
 The regulation of cell cycle progression in parasitic protists differs in important respects from 
that of higher eukaryotes (reviewed in [76]). The main kinases driving the cell cycle in higher 
eukaryotes are the CDK, Aurora, NEK and Polo kinases (reviewed in [77]). Seven enzymes related to 
cyclin-dependent kinases (CDK) are known to exist in P. falciparum, two of which are universally 
shared with other alveolates and metazoans (Pfcrk-1 and PfPK5), while Pfmrk is shared with other 
alveolates, and four are found in apicomplexans only (Pfcrk-3, Pfcrk-4, Pfcrk-5 and PfPK6). PfPK5 is 
the only apicomplexan CDK whose three-dimensional structure has been solved [78]; although its fold 
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is very similar to that of human CDK2, subtle differences in the mode of binding of some inhibitors 
(some of which significantly differ in their IC50 values against CDK2 and PfPK5) lend hope that the 
development of selective inhibitors may be achievable. 
 Cyclin-dependent kinase-like kinases (CLKs) are major regulators of mRNA splicing in 
higher eukaryotes. They function by phosphorylating Serine/Arginine-rich (SR) proteins functioning in 
the RNA processing pathway [79]. P. falciparum has 4 CLKs (PfCLK1-4, Fig. 2 and Table S1), all of 
which are essential enzymes. PfCLK1/Lammer (PF14_0431) and PfCLK3 (PF11_0156) have 
homologues both in other alveolates and metazoans. PfCLK2 (PF14_0408) and PfCLK4 (PFC0105w) 
are shared with other alveolates only. Given that only a handful transcription factors have been 
identified in P. falciparum, it is believed that post-transcriptional control may be crucial for the 
regulation of gene expression. Besides antisense RNA and translational repression, mRNA splicing has 
been documented in P. falciparum [80]. Recently, Agarwal et al. showed that PfCLK1/Lammer and 
PfCLK2 primarily localize to the nucleus and are transcribed throughout the asexual blood stages and 
in gametocytes [81]. Moreover, and as shown by reverse genetics, these two enzymes are necessary for 
completion of the parasite’s asexual replication cycle. Dixit et al. also showed that PfCLK4 (which 
they refer to as PfSRPK1) inhibits mRNA splicing by phosphorylating PfSR1, a putative splicing 
factor known to interact with RNA [82]. 
 Aurora kinases constitute a family of Ser/Thr protein kinases with essential roles in eukaryotic 
cell division, notably in the G2 to cytokinesis transition, and dysregulation of Aurora kinase function 
has been implicated in tumorigenesis. In metazoans, A-type Auroras regulate spindle assembly while 
B-type Auroras promote chromosome segregation and cytokinesis. Malaria parasites possess three 
kinases related to this family, one of which (PfARK1) has been characterised in detail and shown to be 
transiently associated with spindle pole bodies [83]. Unsuccessful attempts at disrupting all aurora 
kinase genes in P. falciparum indicate that they are essential enzymes. See [83] for a phylogenetic 
analysis of P. falciparum Aurora kinases. 
 Members of the NEK family are not associated to any of the established PK groups and are 
therefore classified with the ‘Other’ PK group. NEKs regulate cell cycle progression and have been 
implicated in the regulation of mitosis and meiosis. Humans possess 11 NEKs [84], whereas the family 
has expanded in trypanosomatids with 20-22 members [51]. Interestingly, the NEKs of Apicomplexa 
show no clear relationship to higher eukaryotic NEKs. Four NEK orthologous groups exist in 
apicomplexans: Pfnek-1 (PFL1370w) is an essential enzyme that phosphorylates one of the two 
parasite MAPKs (Pfmap-2) and may play a role in its regulation [85]. Pfnek-1 homologues are found in 
all apicomplexans and other alveolates (but not metazoans). Pfnek-4 (MAL7P1.100) appears to have 
been lost from piroplasmids and gregarines, although the P. berghei orthologue is essential for the 
completion of meiosis [86]. Pfnek-2 (PFE1290w) and Pfnek-3 (PFL0080c) are restricted to 
haemosporidians. Pfnek-2 is essential for transmission to the mosquito, and studies with the P. berghei 
orthologues identified a defect in meiosis in parasites lacking the enzyme, as was the case for Pbnek-4 
[86, 87]. Pfnek-3 has been reported to activate Pfmap-2 in vitro, like Pfnek-1 [88]. A succinct 
phylogenetic tree of Plasmodium NEKs in relation to other members of the family has been published 
[86], and a more thorough analysis is in preparation (Luc Reininger, personal communication). 
 Polo kinases are required at several key points during mitosis in higher eukaryotes, starting 
from control of the G2/M transition through phosphorylation of Cdc25C and mitotic cyclins [89]. 
Yeast has one Polo kinase (Cdc5) that controls the targeting and activation of the small guanine 
nucleotide triphosphate-binding protein RhoA, thereby providing the link between the cell cycle 
machinery and the cytoskeletal proteins controlling cytokinesis [90]. Through sequence analysis we 
failed to identify Polo kinases in apicomplexans, and no parasitic kinases were found to harbour the 
characteristic Polo domain (which mediates multiple protein-protein interactions). This suggests that 
the Polo kinase functions are absent from apicomplexans (in striking contrast with trypanosomatids, 
where Polo kinases have been characterized [91]), or that they are executed in a different way. In yeast, 
Cdc5 phosphorylates and activates the Anaphase Promoting Complex (APC). The P. falciparum kinase 
found to be closest sequence-wise to higher eukaryotic Polo kinases is PfPKA, and yeast/mammalian 
PKA is also known to phosphorylate APC with the opposite effect of suppressing its activity [92]. 
Therefore, Polo kinases and PKA regulate mitotic progression by controlling APC activity in opposing 
ways. Since apicomplexans, but not trypanosomatids, appear to lack true Polo kinases, it appears that 
the metaphase-anaphase transition and exit from mitosis are regulated differently in these two phyla of 
parasitic protists. 
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2.7. The STE group 
 
The STE group includes many kinases functioning in MAP kinase cascades. MAP kinases are activated 
by phosphorylation of their activation loops by MAP kinase kinases (MAPKK), which belong to the 
STE group and are entirely lacking in apicomplexans as previously suggested [10, 93]. In fact, STE 
kinases are sparsely represented in apicomplexans (and entirely absent from Theileria), and do not 
appear to have homologues in other alveolates or metazoan species. This suggests that these are 
important lineage-specific kinases (Fig. 2, Table S1). In striking contrast, STE is the second largest 
group in trypanosomatids, with 25 members in T. brucei and 31 and 34 members in T. cruzi and L. 
major, respectively [51]. A Leishmania MAPKK has been shown to regulate flagellum length [94]. 
 
2.8. The TKL group 
 
The TKL (tyrosine kinase-like kinases) are similar to tyrosine kinases sequence-wise, but catalytically 
are serine/threonine kinases. Six orthologous groups of TKLs were found to be conserved in 
plasmodial species (Fig. 2, Table S1). PfTKL3 (PF13_0258), whose activity requires an accessory 
SAM domain mediating oligomerisation, is essential for asexual parasite proliferation and has recently 
been validated as a drug target through reverse genetics [95]. It is noteworthy that two other kinases 
related to TKLs, PfTKL1 (PFB050w) and PF11_0079, are both among the few proteins in the P. 
falciparum proteome that contain SAM domains, like PfTKL3 [95].  
 
2.9. Apicomplexa-specific groups: FIKK and Rhoptry kinases 
 
The FIKK were first identified in P. falciparum as a set of 20 ePKs forming a tight cluster not clearly 
related to any known ePK group (Ward et al., 2004). The FIKK were named after an amino acid motif 
(Phe-Ile-Lys-Lys) in subdomain II of their kinase catalytic domain, and all P. falciparum FIKK kinases 
have a variable extension N-terminal to their catalytic domain. This N-terminal region has no 
recognizable domains except for a PEXEL export signal [96]. Our analysis agrees with previous 
results: FIKKs are restricted to the Apicomplexa phylum (one gene per species), and are absent from B. 
bovis and Theileria species. The FIKK are expanded in P. falciparum (19 enzymes) with one likely 
founding member (MAL8P1.203, Fig. 2, Table S1), whose orthologue in P. berghei is likely essential 
for asexual erythrocytic proliferation [34]. The FIKK paralogues are all transcribed at some stage of the 
cell cycle of the malaria parasite and have been suspected to be involved in antigenic variation. Recent 
work showed that at least some FIKKs are exported into the cytoplasm of the red blood cell to distinct 
locations and that at least some of these enzymes are catalytically active (or at least associate with 
other PKs) [97, 98]. 
 Rhoptry kinases (ROPK) are a recently described group of PKs of the rhoptries of T. gondii, 
with as many as 34 members [35]. ROPKs are serine/threonine PKs, and their high sequence 
divergence, and the fact that they seem to be restricted to T. gondii [35] indicates that they play specific 
roles in Toxoplasma infection and may have non-redundant substrates. A recent study implicates a 
secreted ROPK in the regulation of transcription of the host cell [35]. Many ROPKs are predicted to be 
catalytically inactive; structurally they share the typical fold of serine/threonine PKs, but they also 
contain a number of insertions unique to ROPKs, suggesting that they may present unique mechanisms 
of activation [99]. 
 
2.10. Atypical PKs 
 
Atypical PKs (aPK) are a small set of kinases that do not share sequence similarity with ePKs, but 
which have been shown experimentally to possess PK activity. The four bona fide aPK families 
include: the Alpha (exemplified by myosin heavy chain kinase of Dictyostelium), PDHK (pyruvate 
dehydrogenase kinase), PIKK (phosphatidyl inositol 3’ kinase-related kinases), and RIO (‘right open 
reading frame’, as it was one of two adjacent genes that were found to be transcribed divergently from 
the same intergenic region) [100]. Apicomplexans possess aPKs of the PIKK and RIO families, 
although none of the apicomplexan aPKs appear to have orthologues in other alveolates or metazoans. 
Two orthologous groups of RIO kinases exist, of which only one is found across all apicomplexan 
species surveyed here. RIO kinases are involved in RNA processing in S. cerevisiae [101]; mammalian 
RIOK3 has recently been shown to negatively regulate NF-kappaB signalling, a pathway of central 
importance in innate immunity responses [102]. PIKKs sense DNA damage, nutrient-dependent 
signalling and nonsense-mediated RNA decay [103]. A set of 4 lineage-specific PDHKs is found in T. 
gondii, but not in other apicomplexans, and are likely to be part of specialized tubular-shaped 
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mitochondrial structures called the Ovoid Mitochondrial Cytoplasmic Complex [104]. PDHKs are also 
present in trypanosomatids [51], suggesting that they might have been lost secondarily from most 
apicomplexan lineages. 
 
2.11. Evolutionary structure-function studies 
 
Talevich et al. recently presented a systematic approach to identify specific sequence and structural 
differences of apicomplexan PKs that are not found in their metazoan orthologues [38]. The authors 
analysed PKs from fifteen apicomplexan genomes and included the available crystallographic 
structures of protein kinases. Their work revealed contrastingly conserved features that were not 
apparent previously. For instance, when analysing the calcium-dependent PKs, the authors found that 
PfCDPK5 orthologues have distinguishing features not found in other CDPKs, including an arginine 
residue in the C helix, and a serine or threonine residue in the activation loop. By integrating 
structural information, Talevich et al. concluded that the conserved arginine residue might function as a 
switch that interacts with the activation loop phospho-threonine to stabilize the C helix in an active 
conformation, a mechanism that would be shared with human p38. With the multitude of 
apicomplexan genomes that are becoming available, and the rapid accumulation of new apicomplexan 
protein structures thanks in part to the Structural Genomics Consortium (SGC) [105], the integrative 
analysis of sequence and structural data, together with the experimental validation of the hypotheses, is 
likely to provide not only an entirely new perspective not only on PK selectivity issues, but also on the 
likely modes of activation and regulation of apicomplexan PKs. Such studies will be very valuable in 
informing the design of specific PK inhibitors. 
 
2.12. Apicomplexan phosphoproteomes 
 
Three separate mass spectrometry-based phosphoproteomic studies have recently brought a turning 
point to our understanding of phosphorylation networks in the malaria parasite (reviewed in Lasonder 
et al. (in press and pages XX in this issue). Solyakov et al. [106] carried out global kinomic and 
phosphoproteomic analyses of the erythrocytic stage of P. falciparum. The authors first showed by 
reverse genetics that 36 out of 65 PKs are essential for the parasite’s survival. The gene loci were 
targeted with knockout targeting vectors that placed an epitope tag in-frame with the PK open reading 
frame. Therefore, the lack of integration could be attributed to the enzyme being essential. This study 
provided solid evidence that an abundant number of essential PKs exist in the malaria parasite and 
which therefore, constitute potential drug targets. The phosphoproteomes of the blood stage of P. 
falciparum were determined by Solyakov et al. [106], Lasonder et al. (in press), and by Treeck et al. 
[107] who also extended their analysis to the phosphoproteome of T. gondii. The technical differences 
among the three studies are analysed by Lasonder et al. (in press and pages XX in this issue) and will 
not be discussed here. These phosphoproteomic studies conclusively acknowledge that protein 
phosphorylation is widespread and plays diverse roles in the parasitic processes, including invasion and 
cyto-adhesion, and also metabolism, cell communication, the cell cycle, DNA replication, transcription 
and translation. The main findings from these studies are: (1) in P. falciparum, 36 out of 65 PKs are 
essential, and many of the orthologous PKs are also essential in the erythrocytic stage of P. berghei 
[34], which suggests that there is little functional redundancy in the parasites’ kinomes; (2) in P. 
falciparum at least 23 PKs are phosphoproteins, many of which are phosphorylated in their activation 
loops. If these are not due to autophosphorylation events, this would suggest the existence of protein 
kinase cascades in the parasites; (3) although apicomplexans lack TKs, a small number of tyrosine 
residues (~2%) are phosphorylated in both P. falciparum and T. gondii. Important tyrosine 
autophosphorylated proteins include PfGSK3 and PfCLK3, both essential enzymes. Human GSK3 
autophosphorylates its own activation loop, as a chaperone-dependent transitional intermediate with 
tyrosine kinase activity. This activity is lost upon autophosphorylation (the enzyme becomes an 
intermolecular serine/threonine kinase) [108]. It will be interesting to determine whether this is an 
ancient mode of regulation present in apicomplexans too; (4) when compared with the 
phosphoproteomes of higher metazoans, P. falciparum contains ~25% unusually phosphorylated motifs 
not found in humans. This could represent an evolutionary adaptation that reflects the unusual amino 
acid composition of the parasite’s proteome and accompanying structural changes in the PKs’ substrate 
binding regions. This could clearly be exploited to design highly specific PK inhibitors; (5) in T. 
gondiii many proteins that are exported into the host cell cytoplasm are phosphorylated, but some of 
these proteins only become phosphorylated once they enter the host cell. This implies that parasitic 
PKs exported along with these proteins regulate the secretome post-translationally, a mechanism that 
might be mimicked by FIKK kinases in P. falciparum; (6) When the phosphoproteomes of T. gondii 
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and P. falciparum are compared, identical phosphorylated residues are observed in homologous regions 
of orthologous proteins. 
 These phosphoproteomic studies open the way for network-based systems biology studies that 
will lead to a deeper understanding of the role of protein phosphorylation in essential parasitic 
processes, and how different signalling pathways are interconnected by reversible protein 
phosphorylation. This will help us understand the effect of PK inhibitors from a network-based 
perspective, which is a more powerful conceptual approach to parasitic intervention. 
 
3. Conclusions 
 
We have presented an exhaustive comparative analysis of twelve apicomplexan kinomes and show that 
these are among the smallest described for eukaryotes. In striking contrast, trypanosomatid kinomes are 
much larger, ranging from 176 PKs (T. brucei) to 199 PKs (L. major), with most PKs being 
orthologous across the three species [51]. Trypanosomatids lack kinases of the RGC, TK, and TKL 
groups, although they possess dual-specificity kinases. Few receptor serine/threonine kinases have 
been predicted in trypanosomatids, and protein domains accessory to the kinase catalytic domain 
appear to be rare too. Similarly, apicomplexans also lack RGCs and TKs and, consequently, PKs with 
SH2 domains. Whereas signalling via accessory domains is a major mode of regulation in human 
kinases and to some extent in trypanosomatids too, our analysis suggests that this is comparatively 
rather limited in apicomplexans. The sensing of the extracellular milieu by receptor kinases is not 
likely to be a major feature of signal transduction in apicomplexans, although a small number of 
kinases were found to contain predicted transmembrane domains.  
 Sixty-five distinct orthologous groups are described across apicomplexan kinomes, of which 
~25% are shared with other alveolates and/or metazoans. About ~75% of apicomplexan PKs are 
specific to this group of parasites. Only 20 PKs are conserved across all apicomplexan lineages 
inspected here (16 of which are essential in the malaria parasite). This set of 20 PKs probably 
represents an indispensable core of PKs for all apicomplexans. The minimal kinome of B. bovis (35 
PKs) contains extensions to this core set of apicomplexan PKs (a further 7 and 5 PKs that are shared 
with P. falciparum or Theileria species, and 3 lineage-specific PKs).  
 The small genomes of apicomplexans (containing between ~3700-8000 genes), together with 
their streamlined kinomes, suggests that apicomplexans, like other parasites, have lost a number of 
genes relative to the nearest free-living eukaryote. Parasites can tolerate massive gene losses as long as 
the host can supply nutrients and a sheltered environment. In fact, it has been estimated that only 
~1000 genes are shared across twelve distinct apicomplexan genomes [109]. This represents less than 
one-third of the protein-coding genes of any apicomplexan, making the rest of the genes lineage-
specific and likely reflecting adaptations to the range of apicomplexan hosts. Since these genes lack 
orthologues outside of the Apicomplexa, they must either have been created de novo or have evolved 
beyond recognition. The genomes of the Apicomplexa are highly dynamic [110] and besides large gene 
gains and losses, they also include large genome rearrangements. Gene losses and genomic 
rearrangements complicate the detection of syntenic relationships across apicomplexan genomes, a 
useful measure in less dynamic genomes of the extent of divergence that has taken place since the 
species last shared a common ancestor. Studies of syntenic relationships in apicomplexan genomes 
showed that whereas significant synteny exists between the genomes of apicomplexans in the same 
genus (e.g. all haemosporidians), no synteny could be detected across the entire phylum due to the 
extensive genome rearrangements. Limited synteny is conserved only between Plasmodium spp. and 
Theileria and Babesia, which clusters haemosporidians and piroplasmids together, followed by 
Toxoplasma and Cryptosporidium [109, 110]. However, synteny is only informative as to the overall 
conservation of genome structure, but not about orthologue conservation. In fact, examination of the 
orthologous groups of PKs conserved across apicomplexans (Fig. 2) would yield a less clear grouping 
of species and geni. This pattern reflects both the need for conservation of biochemical function over 
genomic rearrangements in evolution, and the existence of lineage-specific expansions. For instance, 
from the comparative very large kinome of T. gondii, only ~1/4 of its PKs are shared with P. 
falciparum, making this coccidian a less than ideal organism for the study of the malaria parasite. At 
the other end of the spectrum, the minimal kinome of B. bovis (35 PKs) still reflects many lineage-
specific expansions: only 20 of its PKs are shared with P. falciparum (of which 16 are essential in the 
malaria parasite). 
 The apicomplexan kinomes discussed here are available through the Kinomer database [111] 
at http://www.compbio.dundee.ac.uk/kinomer/. 
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SUPPLEMENTARY MATERIALS AND METHODS 
 
Identification and classification of apicomplexan PKs  
 
The identification and group-level classification of PKs was done by scanning the various predicted 
peptide datasets with a multi-level profile hidden Markov model (HMM) library of the PK superfamily 
[100], under HMMER3 [112], and as detailed in [111]. Since HMMER3 uses a scoring system that is 
different from that of HMMER2, we re-calculated our HMM library scores to correct for HMMER3’s 
increased sensitivity. This was done by working out the E-value score for the worst-scoring PK of each 
specific PK group from the kinomes of H. sapiens, M. musculus, D. melanogaster, C. elegans, S. 
cerevisiae and D. discoideum. These new E-value cutoff scores were uniformly applied to the 
apicomplexan peptide datasets to classify PKs into groups. Our HMM library has previously been 
applied in the kinome characterization of Trichomonas vaginalis [113], Brugia malayi [114], E. 
cuniculi [115],  the fungi Rhizopus oryzae [116] and Fusarium ssp. [117], and the algae Ectocarpus 
siliculosus [118] and Chlamydomonas reinhardtii [119]. 
 The apicomplexan peptide datasets were downloaded from the following public databases: 
PlasmoDB [120] (release 8.2) for the annotated peptides of all Plasmodium species investigated here, 
CryptoDB (release 4.6) [120, 121] for the annotated peptides of C. parvum and C. hominis, the 
Wellcome Trust Sanger Institute’s FTP site (ftp.sanger.ac.uk) for T. annulata, the EMBL database for 
B. bovis (accession number AAXT00000000), and ToxoDB  release 7.2 [36] for the annotated peptides 
of T. gondii type II strain (ME49). The T. parva peptide dataset had previously been downloaded from 
the now discontinued TIGR website (www.tigr.org/tdb/e2k1/tpa1/). Furthermore, a number of 
additional alveolate and metazoan kinomes were included to investigate homology. For some of these, 
the predicted peptides were downloaded from their respective databases and analysed as above, or their 
kinomes were readily available. These include the diatom Phaeodactylum tricornutum (JGI v. 2.0, 
10,402 peptides), the water molds Phytophthora ramorum (JGI v. 1.1, 15,743 peptides) and 
Phytophthora sojae (JGI v. 1.1, 19,027 peptides), the model ciliate Paramecium tetraurelia  
(ParameciumDB, v. 1.43, 39,541 peptides), the ciliate Tetrahymena thermophila (KinBase: 
http://www.kinase.com/kinbase/) and the diatom Thalassiosira pseudonana (Kinomer v. 1.0 [111]). 
The fungal and metazoan kinomes were downloaded from the Kinomer v. 1.0 database [111] and 
include those of S. cerevisiae, D. melanogaster, C. elegans  and H. sapiens. The identification of non-
kinase accessory protein domains, transmembrane helices and signal peptides was performed with a 
local installation of InterProScan [122] run with default parameters. 
 
Phylogenetic analysis 
 
To identify homology relationships among apicomplexan PKs and those of alveolates and metazoans, 
all kinase catalytic domain sequences were compared pairwise, followed by complete clustering on z-
scores calculated from randomized sequences with the Amps suite of programs [123]. This allowed the 
selection of homologous alveolate and metazoan sequences that were subsequently included in multiple 
sequence alignments of each PK group. The alignments were inspected and curated for large 
insertions/deletions and mis-aligned regions under Jalview [124]. Phylogenetic trees were 
reconstructed using three alternative strategies. Firstly, Neighbor Joining trees were reconstructed as 
implemented in BioNJ [125] and support for the different partitions was computed based on a bootstrap 
analysis of 100 alignment replicas. Secondly, Maximum Likelihood trees were reconstructed as 
implemented in PhyML v3.0 [126], using four alternative evolutionary models (LG, WAG, VT and 
JTT). The model best fitting the data according to the AIC criterion [127] was chosen for subsequent 
analyses. In all cases a discrete gamma-distribution model with four rate categories plus invariant 
positions was used, the gamma parameter and the fraction of invariant positions were estimated from 
the data. Support values were computed using approximate likelihood ratio test statistics (aLRT) using 
the option “minimum of -SH and Chi2 statistics” as implemented in PhyML [128]. Finally, Bayesian 
analyses were ran using PhyloBayes v. 3.2 [129] and the CAT model, two MCMC chains were ran 
until convergence (using maxdiff < 0.1 and effective size > 100 thresholds). Consensus trees were 
computed, after removing the first 20% of trees, using the majority rule. Support values for the 
different partitions correspond to posterior probabilities. A strict consensus of all three methods was 
built that shows only partitions recovered by all three approaches (ML, NJ and Bayesian).   
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TABLES 
 
Table 1. The kinomes of the 12 apicomplexan genomes classified into the various ePK and aPK 
groups. The Rhoptry kinases of T. gondii are included as part of the OPK group of this parasite. 
 
Kin
ase 
grou
p 
P. 
berg
hei 
P. 
chab
audi 
P. 
falcipa
rum 
P. 
know
lesi 
P. 
viv
ax 
P. 
yoe
lii 
C. 
homi
nis 
C. 
parv
um 
T. 
gon
dii 
B. 
bo
vis 
T. 
annu
lata 
T. 
par
va 
To
tal 
AG
C 
6 6 6 6 6 7 5 6 15 4 4 4 75 
CA
MK 
17 18 19 18 18 18 12 15 29 7 9 10 19
0 
CK1 1 1 1 1 1 1 2 2 3 1 1 1 16 
CM
GC 
21 19 22 21 23 22 16 18 20 15 16 16 22
9 
STE 1 1 2 2 2 1 4 6 2 1 1 1 24 
TK
L 
4 7 6 7 5 4 5 4 6 0 0 0 48 
NE
K 
4 3 4 4 4 3 2 3 4 1 1 1 34 
FIK
K 
1 1 19 1 1 1 1 1 1 0 0 0 27 
OP
K 
4 2 5 4 3 3 0 0 41  0 0 0 62 
PD
HK 
0 0 0 0 0 0 0 0 4 0 0 0 4 
PIK
K 
1 2 3 2 3 1 4 4 8 4 3 3 38 
RIO 2 1 2 2 2 2 1 2 2 2 2 2 22 
Tota
l  
62 61 89 68 68 63 52 61 135 35 37 38 76
9 
 
 
 
Table 2. Conservation of apicomplexan PKs in non-apicomplexan alveolates and metazoans. 
 
Group Orthologous 
groups 
+apicomplexans 
+alveolates 
+metazoans 
+apicomplexans 
+alveolates 
-metazoans 
apicomplexans 
only 
AGC 6 3 0 3 
CAMK 18 1 1 16 
CK1 1 0 0 1 
CMGC 22 7 4 11 
STE 1 0 0 1 
TKL 6 0 0 6 
NEK 4 0 1 3 
FIKK 2 0 0 2 
PIKK 3 0 0 3 
RIO 2 0 0 2 
Total 65 11 6 48 
 
 
LIST OF FIGURES 
 
Fig. 1. Bar chart of the apicomplexan kinomes split by PK group and in comparison with the kinomes 
of the model organisms H. sapiens, D. melanogaster, C. elegans and S. cerevisiae. The PK groups of 
all species are displayed as a percentage of the organisms’ entire kinome. The relative percentages of 
each PK group are approximately constant across the apicomplexans and the opisthokonts. The OPK 
	 13
group of T. gondii appears disproportionately larger as it contains all the Rhoptry kinases, which are 
specific to Toxoplasma. 
 
Fig. 2. Conservation of apicomplexan orthologous kinase groups in alveolates and metazoans. Empty 
circles indicate ‘absent’, whereas fully coloured circles indicate ‘present’. The 36 essential PKs of P. 
falciparum are highlighted in red. 
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Table S1. Orthology relationships of the 12 apicomplexan kinomes. 
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PK (protein kinase); ePK (conventional PK); aPK (atypical PK); OPK (‘Other’ PK); HMM (profile 
hidden Markov model). 
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